Lv1
70 积分 2024-03-06 加入
Do we need another TKI for chronic myeloid leukaemia?
8天前
已完结
Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting
1个月前
已完结
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual targeting antibody overcome antigen heterogeneity in AML
2个月前
已关闭
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
2个月前
已关闭
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
2个月前
已关闭
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
2个月前
已关闭
FDA-approved therapies for chronic GVHD
2个月前
已关闭
Current myeloproliferative neoplasm scoring systems for clinical practice
2个月前
已关闭
Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions
2个月前
已完结
皖公网安备34019202002308
